What are the differences in etiology, diagnosis, and treatment between primary (Addison’s disease) and secondary hypocortisolism?

Primary vs Secondary Hypocortisolism: Key Differences

Primary adrenal insufficiency (Addison's disease) requires both glucocorticoid AND mineralocorticoid replacement, while secondary adrenal insufficiency requires only glucocorticoid replacement—this fundamental treatment difference stems from the preserved renin-angiotensin-aldosterone system in secondary disease.

Etiology

Primary Adrenal Insufficiency (Addison's Disease)

• Autoimmune adrenalitis is the predominant cause in developed countries 1
• Other causes include:
  • Tuberculosis (historically common, still relevant in endemic areas) 2
  • Adrenal hemorrhage from severe stress, trauma, or coagulopathies 2
  • Metastatic malignancy to adrenal glands 2
  • Genetic disorders (e.g., adrenoleukodystrophy) 2
  • Bilateral adrenalectomy or medications inhibiting steroidogenesis 2

The pathology directly destroys the adrenal cortex, eliminating production of both cortisol and aldosterone 3.

Secondary Adrenal Insufficiency

• Pituitary or hypothalamic dysfunction causing ACTH deficiency 3
• Iatrogenic suppression from exogenous glucocorticoids is by far the most common cause—the prevalence vastly exceeds primary AI 4
• Pituitary tumors, surgery, radiation, or infiltrative disease 4
• Abrupt discontinuation of chronic glucocorticoid therapy causes HPA axis suppression and adrenal atrophy 3

The zona glomerulosa (aldosterone production) remains intact because it's regulated by the renin-angiotensin system, not ACTH 3.

Diagnosis

Primary Adrenal Insufficiency

The diagnostic triad consists of:

1. Low morning cortisol <140 nmol/L (5 μg/dL) 1
2. Elevated ACTH >2-fold above upper limit of normal (>66 pmol/L represents maximal stimulus) 1
3. Low DHEAS well below normal for age/sex (useful initial sign but cannot diagnose in isolation) 1

Confirmatory testing:

• ACTH stimulation test (250 μg cosyntropin) is the diagnostic gold standard for primary AI 1
• Measure cortisol at baseline and 30-60 minutes post-administration
• Sensitivity of 92% (95% CI: 81-97%) for primary AI 1
• The test can be performed at any time of day (not affected by diurnal variation) 1

Critical pitfall: Approximately 10% of patients with early primary AI present with normal basal cortisol concentrations despite clearly elevated ACTH 5. When clinical suspicion is high and ACTH is markedly elevated (>300 pg/mL), proceed with ACTH stimulation testing even if morning cortisol appears normal 5.

Additional features specific to primary AI:

• Skin hyperpigmentation (from elevated ACTH and melanocyte-stimulating hormone) 6
• Hyperkalemia and salt craving (from aldosterone deficiency) 6
• Hyponatremia (present in both types but more severe in primary) 6

Secondary Adrenal Insufficiency

Diagnostic approach differs significantly:

• Low or low-normal cortisol with LOW or inappropriately normal ACTH 7
• ACTH stimulation test is LESS reliable for secondary AI—patients may pass the standard 250 μg test yet still have HPA axis dysfunction 4
• The low-dose (1 μg) ACTH test shows no significant diagnostic advantage over the 250 μg test 1

For definitive diagnosis of secondary AI:

• Insulin tolerance test (ITT) is considered the gold standard as it tests the entire HPA axis 4
• Alternative: Metyrapone test when ITT is contraindicated 7
• Important caveat: Some patients pass the ITT but fail the ACTH test, highlighting the complexity of diagnosis 4

In mild or recent-onset secondary AI, cosyntropin tests (either dose) often give false-negative results 4. A negative test does NOT rule out secondary AI 4.

For glucocorticoid-induced AI specifically:

• Consider testing in any patient who received glucocorticoid-equivalent doses for prolonged periods 8
• Recovery can take >4 years after cessation; persistent impairment beyond 4 years suggests permanent dysfunction requiring long-term replacement 8

Key Diagnostic Distinction

No hyperpigmentation, no hyperkalemia, and no salt craving in secondary AI because ACTH is low and aldosterone production is preserved 6.

Treatment

Primary Adrenal Insufficiency

Dual hormone replacement is mandatory:

Glucocorticoid replacement:

• Hydrocortisone is preferred (mimics physiologic cortisol) 1
• Typical dosing: 15-25 mg/day divided into 2-3 doses 1
• Dosing schedule example: 10 mg on waking, 5 mg at lunch, 5 mg early evening (mimicking diurnal rhythm)
• No significant HRQoL difference between regimens ≥30 mg/day vs <30 mg/day 1

Mineralocorticoid replacement:

• Fludrocortisone 50-200 μg daily (typically 100 μg) 1
• Not required if hydrocortisone dose exceeds 50 mg/24 hours (provides sufficient mineralocorticoid activity) 1
• 40 mg hydrocortisone ≈ 100 μg fludrocortisone equivalence 1

Secondary Adrenal Insufficiency

Glucocorticoid replacement ONLY:

• Same hydrocortisone regimen as primary AI (15-25 mg/day divided) 1
• No fludrocortisone needed because aldosterone production is intact 3

Stress Dosing (Both Types)

For minor stress (fever, infection with antibiotics, minor trauma, local anesthesia):

• Double the usual daily dose until stress resolves 1, 8
• Example: 40 mg hydrocortisone daily (20 mg morning, 10 mg midday, 10 mg evening) 8

For moderate-major stress (severe illness requiring hospitalization, major surgery, general anesthesia):

• Parenteral hydrocortisone 100 mg IV/IM bolus immediately 1
• Continue with 50-100 mg every 6-8 hours or continuous infusion 1
• Traditional teaching: 75-100 mg/day for major surgery, 50 mg/day for minor surgery 1

For adrenal crisis:

• Immediate IV hydrocortisone 100 mg bolus 1
• Aggressive IV fluid resuscitation 9
• Continue hydrocortisone 50-100 mg every 6-8 hours 1
• This is life-threatening and requires immediate treatment—do not delay for diagnostic testing 1

Critical for patient safety:

• All patients must carry emergency glucocorticoid injection kit 9
• Subcutaneous self-injection is preferred by patients (reaches therapeutic levels in 22 minutes vs 11 minutes for IM, but still acceptable) 1
• Issue emergency steroid identification card 9
• Repeated patient and family education on stress dosing and crisis recognition 9

Monitoring and Follow-up

Primary AI:

• Monitor for both over-replacement (weight gain, hypertension, hyperglycemia) and under-replacement (persistent symptoms, weight loss)
• Check electrolytes, blood pressure, and clinical symptoms regularly
• Adjust fludrocortisone based on blood pressure, edema, and electrolytes

Secondary AI:

• Same glucocorticoid monitoring as primary AI
• No need to monitor aldosterone-related parameters
• If AI persists >1 year on physiologic replacement, refer to endocrinology to evaluate for other causes (pituitary pathology) 8

Glucocorticoid-induced AI:

• Biochemical testing should be performed to confirm HPA axis recovery before discontinuing stress-dose precautions 8
• Mortality increases immediately following glucocorticoid cessation in untested patients 8